SCN2B
Sodium channel regulatory subunit beta-2
Also known as: SCN2B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60939
- Gene
- SCN2B
- Ensembl
- ENSG00000149575
- Chromosome
- 11
- Canonical length
- 215 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene is the beta 2 subunit of the type II voltage-gated sodium channel. The encoded protein is involved in cell-cell adhesion and cell migration. Defects in this gene can be a cause of Brugada Syndrome, atrial fibrillation, or sudden infant death syndrome. [provided by RefSeq, Jul 2015]
Canonical amino-acid sequenceUniProt
215 residues, UniProt reviewed canonical sequence.
>O60939|SCN2B
1 MHRDAWLPRP AFSLTGLSLF FSLVPPGRSM EVTVPATLNV LNGSDARLPC TFNSCYTVNH
61 KQFSLNWTYQ ECNNCSEEMF LQFRMKIINL KLERFQDRVE FSGNPSKYDV SVMLRNVQPE
121 DEGIYNCYIM NPPDRHRGHG KIHLQVLMEE PPERDSTVAV IVGASVGGFL AVVILVLMVV
181 KCVRRKKEQK LSTDDLKTEE EGKTDGEGNP DDGAKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SCN2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 48 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 48 nTPM
- cerebral cortex: 38 nTPM
- basal ganglia: 32 nTPM
- hippocampal formation: 17 nTPM
- hypothalamus: 17 nTPM
- amygdala: 16 nTPM
Single-cell type
- brain inhibitory neurons: 34 nCPM
- other brain neurons: 28 nCPM
- retinal amacrine cells: 28 nCPM
- brain excitatory neurons: 28 nCPM
- retinal ganglion cells: 16 nCPM
- retinal horizontal cells: 10 nCPM
Immune cell
- basophil: 0.3 nTPM
- neutrophil: 0.2 nTPM
- eosinophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 96 nTPM
- white matter: 70 nTPM
- hippocampal formation: 69 nTPM
- basal ganglia: 68 nTPM
- thalamus: 67 nTPM
- amygdala: 57 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SCN2B.
Disease | AllUniProt
Conditions SCN2B is implicated in, by any mechanism.
- Atrial fibrillation, familial, 14 (ATFB14) MIM:615378
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.4
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiac conduction
- cardiac muscle cell action potential involved in contraction
- cardiac muscle contraction
- chemical synaptic transmission
- gene expression
- membrane depolarization during action potential
- membrane depolarization during cardiac muscle cell action potential
- nervous system development
- positive regulation of sodium ion transport
- regulation of atrial cardiac muscle cell membrane depolarization
- regulation of heart rate by cardiac conduction
- response to heat
- response to pyrethroid
Molecular functions
- sodium channel regulator activity
- voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization
- voltage-gated sodium channel activity involved in cardiac muscle cell action potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SCN2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SCN2B as an antibody target. Whether an autoantibody or antibody against SCN2B could matter depends on whether native SCN2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SCN2B is annotated at the cell surface, where native SCN2B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SCN2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...